Candesartan improves survival following severe hypovolemia in pigs; a role for the angiotensin II type 2 receptor?

Intensive Care Medicine

Volumn 31, Issue 8, 2005, Pages 1109-1115

  Laesser, Mats ^a   Spak, Emma ^a   Ewert, Sara ^a   Aneman, Anders ^a   Fandriks, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Angiotensin II receptors; Candesartan; Gastrointestinal; Hemorrhage; PD123319; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HYPOVOLEMIA; MALE; MORTALITY; NONHUMAN; PROSPECTIVE STUDY; SURVIVAL; SWINE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; FEMALE; HEMODYNAMIC PROCESSES; HYPOVOLEMIA; MALE; PROSPECTIVE STUDIES; RECEPTOR, ANGIOTENSIN, TYPE 2; SURVIVAL RATE; SWINE; TETRAZOLES; TREATMENT OUTCOME;

EID: 23744451717     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-2686-1     Document Type: Article

References (26)

1. Swank GM, Deitch EA (1996) Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20:411-417
2. Landow L, Andersen LW (1994) Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 38:626-639
3. Toung T, Reilly PM, Fuh KC, Ferris R, Bulkley GB (2000) Mesenteric vasoconstriction in response to hemorrhagic shock. Shock 13:267-273
4. Kuebler JF, Jarrar D, Toth B, Bland KI, Rue L, 3rd, Wang P, Chaudry IH (2002) Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 137:74-79
5. Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y (2002) Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 71:381-388
6. Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A (2003) Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 21:1429-1443
7. Laesser M, Fandriks L, Pettersson A, Ewert S, Aneman A (2000) Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. Shock 14:471-477
8. Aneman A, Svensson M, Broome M, Biber B, Petterson A, Fandriks L (2000) Specific angiotensin II receptor blockage improves intestinal perfusion during graded hypovolemia in pigs. Crit Care Med 28:818-823
9. Oldner A, Wanecek M, Weitzberg E, Rundgren M, Alving K, Ullman J, Rudehill A (1999) Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock. Shock 11:127-135
10. Widdop RE, Jones ES, Hannan RE, Gaspari TA (2003) Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 140:809-824
11. Carey RM, Jin X, Wang Z, Siragy HM (2000) Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 168:65-71
12. Siragy HM, Carey RM (1999) Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33:1237-1242
13. Snygg J, Casselbrant A, Pettersson A, Holm M, Fandriks L, Aneman A (2000) Tonometric assessment of jejunal mucosal nitric oxide formation in anaesthetized pigs. Acta Physiol Scand 169:39-45
14. Ewert S, Laesser M, Johansson B, Holm M, Aneman A, Fandriks L (2003) The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa. BMC Pharmacol 3:2
15. Engelhardt V (1966) Swine cardiovascular physiology - a review. In: Bustard LK (ed) MR swine in biomedical research. Frayn, Seattle, pp 307-329
16. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238-1246
17. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
18. Aneman A, Pettersson A, Eisenhofer G, Friberg P, Holm M, von Bothmer C, Fandriks L (1997) Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock 8:378-384
19. Abdelrahman AM, Burrell LM, Johnston CI (1993) Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. J Hypertens Suppl 11:S23-S26
20. Millatt LJ, Abdel-Rahman EM, Siragy HM (1999) Angiotensin II and nitric oxide: a question of balance. Regul Pept 81:1-10
21. Wallace JL, Miller MJ (2000) Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119:512-520
22. Izzo AA, Mascolo N, Capasso F (1998) Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 43:1605-1620
23. Snygg J, Aneman A, Pettersson A, Fandriks L (2000) Jejunal mucosal nitric oxide production and substrate dependency during acute mesenteric hypoperfusion in pigs. Crit Care Med 28:2563-2566
24. Snygg J, Fandriks L, Bengtsson J, Holm M, Pettersson A, Aneman A (2001) Jejunal luminal nitric oxide during severe hypovolemia and sepsis in anesthetized pigs. Intensive Care Med 27:1807-1813
25. Hojgaard L (1991) Gastric potential difference measurements. The gastric mucosal integrity and function studied with a new method for measurement of the electric potential difference across the stomach wall. Scand J Gastroenterol Suppl 184:1-27
26. Newton CR, Curran B, Victorino GP (2004) Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability. Surgery 136:1054-1060